The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with pathogenic mechanisms that may be driven by innate immune pathways. The goal of this study is to characterize the expression of the structural (S, E, M, N) and accessory (ORF 3, ORF 4a, ORF 4b, ORF 5) proteins of MERS-CoV and to determine whether any of these proteins acts as an interferon antagonist. Individual structural and accessory protein-coding plasmids with an N-terminal HA tag were constructed and transiently transfected into cells, and their native expression and subcellular localization were assessed using Wes tern blotting and indirect immunofluorescence. While ORF 4b demonstrated majorly nuclear localization, all of the other proteins demonstrated cytoplasmic localization. In addition, for the first time, our experiments revealed that the M, ORF 4a, ORF 4b, and ORF 5 proteins are potent interferon antagonists. Further examination revealed that the ORF 4a protein of MERS-CoV has the most potential to counteract the antiviral effects of IFN via the inhibition of both the interferon production (IFN-β promoter activity, IRF-3/7 and NF-κB activation) and ISRE promoter element signaling pathways. Together, our results provide new insights into the function and pathogenic role of the structural and accessory proteins of MERS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · cited 3×
“For MERS-CoV, Dipeptidyl peptidase 4 (DPP4) is the receptor, while for SARS-CoV, the receptor is angiotensin-converting enzyme 2 (ACE2) (Raj et al., 2013).”
BackgroundThe Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01244-13 · Cited by 1,236
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
Sun, W., Li, Y., Chen, L., Chen, H., You, F., Zhou, X., Zhou, Y., Zhai, Z., Chen, D., & Jiang, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900850106 · Cited by 866
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 739
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463 · cited 2×
“Similar to other highly pathogenic viruses, such as the Nipah virus (Shaw et al., 2009) , MHV (Ye et al., 2007; Koetzner et al., 2010; Zhao et al., 2011) , SARS-CoV (Devaraj et al., 2007; Frieman et al., 2007; Kopecky-Bromberg et al., 2007; Frieman et al., 2009; Siu et al., 2009; Lu et al., 2011; Sun et al., 2012) , a…”
BackgroundMultiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein
Kochs, G., García-Sastre, A., & Martínez-Sobrido, L. (2007) · Journal of Virology · doi:10.1128/jvi.02581-06 · Cited by 445
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 415
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411 · cited 8×
“…proteins (van Boheemen et al., 2012); it thus remains a possibility that one or more of these products also inhibit the interferon response, much like SARS-CoV (Devaraj et al., 2007; Wathelet et al., 2007; Frieman et al., 2009; Kamitani, et al., 2009; Huang et al., 2011; Sun et al., 2012).”
BackgroundInfluentialA two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein
Kamitani, W., Huang, C., Narayanan, K., Lokugamage, K. G., & Makino, S. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1680 · Cited by 409
Breban, R., Riou, J., & Fontanet, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61492-0 · Cited by 385
Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 368
Huang, C., Lokugamage, K. G., Rozovics, J. M., Narayanan, K., Semler, B. L., & Makino, S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002433 · Cited by 352
de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
Wathelet, M. G., Orr, M., Frieman, M. B., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00702-07 · Cited by 345
Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., & Jin, D.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008227 · Cited by 272
Nal, B., Chan, C., Kien, F., Siu, L., Tse, J., Chu, K., Kam, J., Staropoli, I., Crescenzo-Chaigne, B., Escriou, N., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80671-0 · Cited by 272
Sun, L., Xing, Y., Chen, X., Zheng, Y., Yang, Y., Nichols, D. B., Clementz, M. A., Banach, B. S., Li, K., Baker, S. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030802 · Cited by 268
Self-citationSubcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Nieto-Torres, J. L., DeDiego, M. L., Álvarez, E., Jiménez-Guardeño, J. M., Regla-Nava, J. A., Llorente, M., Kremer, L., Shuo, S., & Enjuanes, L. (2011) · Virology · doi:10.1016/j.virol.2011.03.029 · Cited by 262
Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses
Wang, B., Xi, X., Lei, X., Zhang, X., Cui, S., Wang, J., Jin, Q., & Zhao, Z. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003231 · Cited by 238
Self-citationCorse, E., & Machamer, C. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4319-4326.2000 · Cited by 236
Lu, X., Pan, J., Tao, J., & Guo, D. (2011) · Virus Genes · doi:10.1007/s11262-010-0544-x · Cited by 235
Wurm, T., Chen, H., Hodgson, T., Britton, P., Brooks, G., & Hiscox, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9345-9356.2001 · Cited by 232
The Coronavirus Infectious Bronchitis Virus Nucleoprotein Localizes to the Nucleolus
Hiscox, J. A., Wurm, T., Wilson, L., Britton, P., Cavanagh, D., & Brooks, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.506-512.2001 · Cited by 214
Lei, X., Liu, X., Ma, Y., Sun, Z., Yang, Y., Jin, Q., He, B., & Wang, J. (2010) · Journal of Virology · doi:10.1128/jvi.02491-09 · Cited by 205
Self-citationSurjit, M., Kumar, R., Mishra, R. N., Reddy, M. K., Chow, V. T. K., & Lal, S. K. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11476-11486.2005 · Cited by 180
Chan, R. W. Y., Chan, M. C. W., Agnihothram, S., Chan, L. L. Y., Kuok, D. I. T., Fong, J. H. M., Guan, Y., Poon, L. L. M., Baric, R. S., Nicholls, J. M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00009-13 · Cited by 178
Recent advances in understanding viral evasion of type I interferon
Taylor, K. E., & Mossman, K. L. (2013) · Immunology · doi:10.1111/imm.12038 · Cited by 167
Lontok, E., Corse, E., & Machamer, C. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5913-5922.2004 · Cited by 156
McBride, R., & Fielding, B. C. (2012) · Viruses · doi:10.3390/v4112902 · Cited by 155
Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist
Ye, Y., Hauns, K., Langland, J., Jacobs, B. L., & Hogue, B. G. (2006) · Journal of Virology · doi:10.1128/jvi.01634-06 · Cited by 123
G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells
Yuan, X., Shan, Y., Zhao, Z., Chen, J., & Cong, Y. (2005) · Virology Journal · doi:10.1186/1743-422x-2-66 · Cited by 119
Self-citationMechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Frieman, M., & Baric, R. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 107
Freundt, E. C., Yu, L., Park, E., Lenardo, M. J., & Xu, X.-N. (2009) · Journal of Virology · doi:10.1128/jvi.00367-09 · Cited by 102
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein
You, J., Dove, B. K., Enjuanes, L., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.81076-0 · Cited by 90
Cell-Type-Specific Type I Interferon Antagonism Influences Organ Tropism of Murine Coronavirus
Zhao, L., Rose, K. M., Elliott, R., van Rooijen, N., & Weiss, S. R. (2011) · Journal of Virology · doi:10.1128/jvi.05075-11 · Cited by 73
Khan, S., Fielding, B. C., Tan, T. H. P., Chou, C.-F., Shen, S., Lim, S. G., Hong, W., & Tan, Y. (2006) · Virus Research · doi:10.1016/j.virusres.2006.06.005 · Cited by 62
Yuan, X., Yao, Z., Shan, Y., Chen, B., Yang, Z., Wu, J., Zhao, Z., Chen, J., & Cong, Y. (2005) · Virus Research · doi:10.1016/j.virusres.2005.06.001 · Cited by 50
Self-citationKoetzner, C. A., Kuo, L., Goebel, S. J., Dean, A. B., Parker, M. M., & Masters, P. S. (2010) · Journal of Virology · doi:10.1128/jvi.00385-10 · Cited by 49
Cited by
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
“The membrane protein of MERS-CoV inhibits IRF3 function and the expression of genes that are regulated by an ISRE, including IFNβ 71 , but whether this occurs through a mechanism similar to that of SARS-CoV is unclear.”
InfluentialChannappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,186
Metadata
- Authors
- Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., & Tan, W.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12
- Volume
- 4
- Issue
- 12
- Pages
- 951-961
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W2053503974
- Cited by
- 277
- References
- 47
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.